drugset / Trial / NCT04655339
Laparoscopic Transversus Abdominis Plane (TAP) Block to Reduce Post-operative Opioids
RandomizedParallel-groupTriple-blindTreatment
Summary
This study evaluates laparoscopic-guided TAP block for reducing opioid use after minimally invasive foregut and bariatric surgeries, comparing Bupivacaine HCL with Exparel®. Secondary outcomes include pain scores, length of stay, and PONV medication use.
Timeline
- Start
- 2020-01-24
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 30 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |